Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial

Peter G. Pappas, Jose A. Vazquez, Ilana Oren, Galia Rahav, Mickael Aoun, Pierre Bulpa, Ronen Ben-Ami, Ricard Ferrer, Todd Mccarty, George R. Thompson, Haran Schlamm, Paul A. Bien, Sara H. Barbat, Pamela Wedel, Iwona Oborska, Margaret Tawadrous, Michael R. Hodges